CNBX Pharmaceuticals Inc. SEC filings CNBX

CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.

Form Description Filed Period
S-1 Registration statement Feb 18, 2022 —
S-1 Registration statement May 10, 2021 —
S-1/A Amended registration statement Feb 23, 2021 —
S-1 Registration statement Jan 27, 2021 —
424B5 Prospectus supplement Sep 26, 2018 —
424B2 Prospectus Sep 12, 2018 —
424B2 Prospectus Aug 21, 2018 —
424B2 Prospectus Jun 1, 2018 —
424B2 Prospectus May 31, 2018 —
424B5 Prospectus supplement May 10, 2017 —
S-3/A Amendment no. 1 Apr 7, 2017 —
S-3 Shelf registration Mar 21, 2017 —
S-1/A Amended registration statement Feb 11, 2014 —
S-1/A Amended registration statement Jan 31, 2014 —
S-1/A Amended registration statement Jan 24, 2014 —
S-1 Registration statement Dec 11, 2013 —
424B3 Prospectus Apr 20, 2006 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CNBX (OTC)
Fiscal year ends
August 31
Incorporated in
NV
Headquarters
Bethesda, MD
SEC filer status
, Emerging growth company
SEC CIK
1343009
Former names
Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.